Dasatinib and Netupitant: Interaction Details
- Dasatinib
- SprycelPhyrago
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Dasatinib and Netupitant interaction:
Netupitant
We don't have a separate drug information page for Netupitant. The FDA's drug directory lists it as part of Akynzeo (netupitant and palonosetron). Read the Netupitant and Palonosetron drug information page → Have a question about Netupitant? Ask a pharmacist, free →
What Happens When You Take Dasatinib With Netupitant
What can happen when they are taken together (rated Major)
Increased exposure of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Netupitant, along with its fosnetupitant, acts as a moderate CYP3A4 , so giving either agent together with CYP3A4 substrates may raise exposure to those substrates. In a study, of netupitant led to higher mean and of erythromycin, a CYP3A4 substrate.
After a single dose of netupitant, the AUC of the CYP3A4 probe substrate dexAMETHasone stayed elevated for as long as 8 days. For this reason, CYP3A4 substrates should not be used concomitantly with netupitant or fosnetupitant for 1 week, and this 1-week avoidance of concomitant use with netupitant is reiterated. When administration of a CYP3A4 substrate within 1 week of netupitant cannot be avoided, a dose reduction of the CYP3A4 substrate should be considered.1
The Dasatinib and Netupitant Interaction, Explained
Netupitant is a medicine that helps prevent nausea and vomiting from chemotherapy (it comes combined with palonosetron as Akynzeo). Dasatinib (Sprycel, Phyrago) is a cancer medicine used for certain types of leukemia. Your body breaks down dasatinib using a liver enzyme called . Netupitant slows that enzyme down, and the effect can last about a week after a single dose.
That means dasatinib could build up in your body, which may raise the chance of side effects like low blood counts, bleeding or bruising, fluid buildup, or diarrhea. This concern is based on how the drugs work, not on direct studies of this exact pair. Your care team can manage this, so talk with your pharmacist or oncologist before any changes.
Mechanism: Netupitant (and its fosnetupitant) is a moderate . Dasatinib is an active drug cleared mainly by CYP3A4, so is expected to increase dasatinib and .
- Onset/duration: Rapid. CYP3A4 persists up to ~8 days after a single netupitant dose (dexamethasone AUC data).
- Evidence: Theoretical for this pair. It is extrapolated from erythromycin and dexamethasone PK studies. The magnitude for dasatinib is not established.
- Risk: Dose-related dasatinib toxicity (, bleeding, fluid retention/pleural effusion, ).
- Management: Avoid coadministration within 1 week of netupitant. If unavoidable, consider dasatinib dose reduction and monitor CBC and for effusion and bleeding.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Dasatinib and Netupitant Interact
The likely mechanism
of -mediated by netupitant
How to Manage the Dasatinib and Netupitant Interaction
The documented guidance is to avoid using these two together within about 1 week of a netupitant dose. Your care team may:
- Plan the timing of your anti-nausea medicine and dasatinib around this window, or choose another anti-nausea option
- Adjust and individualize your dasatinib dose if both are needed within that week
- Monitor you more closely for side effects
What you can do: Keep taking your medicines as prescribed. Make sure your oncologist and pharmacist know you take dasatinib before chemotherapy anti-nausea medicines are given. Report unusual bruising, bleeding, swelling, or shortness of breath.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Dasatinib or Netupitant need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
2 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: AKYNZEO oral capsules, netupitant palonosetron oral capsules
One study evaluated how long persisted by using dexAMETHasone as a CYP3A4 probe . Participants received a dexAMETHasone regimen of 12 mg on day 1, followed by 8 mg on days 2, 3, 4, 6, 8, and 10, and were given a single dose of the combination netupitant 300 mg/palonosetron 0.5 mg on day 1. Relative to dexAMETHasone alone, the mean of dexAMETHasone rose by 1.6-fold on day 1, 2.4-fold on day 4, 1.5-fold on day 6, and 1.2-fold on day 8.1
-
Report 2 · Study title
Prescribing information: AKYNZEO oral capsules, netupitant palonosetron oral capsules
In a study, of erythromycin 500 mg with netupitant 300 mg resulted in a 56% increase in the mean of erythromycin and a 92% increase in its .1
Dasatinib and Netupitant: Common Questions
How serious is the Dasatinib and Netupitant interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Dasatinib and Netupitant interaction managed?
The documented guidance is to avoid using these two together within about 1 week of a netupitant dose. Your care team may: Plan the timing of your anti-nausea medicine and dasatinib around this window, or choose another anti-nausea option Adjust and individualize your dasatinib dose if both are needed within that week Monitor you more closely for side effects What you can do: Keep taking your medi… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "rapid". Effects can appear quickly, often within about 24 hours of combining the drugs.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Dasatinib and Netupitant Interaction
Ask in your own words about taking Dasatinib and Netupitant together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: AKYNZEO(R) oral capsules, netupitant palonosetron oral capsules. Helsinn Therapeutics (US), Inc (per FDA), Iselin, NJ, 2018. DailyMed
Other Serious Interactions of Dasatinib and Netupitant
Also serious with Netupitant
Also serious with Dasatinib
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Dasatinib
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- American HelleboreMajor
- ArsenicMajor
- CesiumMajor
- EphedraMajor
- Sida CordifoliaMajor
- + 143 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs. This interaction.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.